Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
TYK Medicines, Inc
* To define the maximum tolerated dose(MTD) and the recommended phase 2 dose (RP2D) * To investigate the pharmacokinetic profile of TY-9591 and its metabolites after single then multiple doses of TY-9591 administered orally once daily * To evaluate the anti-cancer activity of TY-9591 in NSCLC patients with EGFR mutation(ORR、PFS、DoR、DCR、and CBR)
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted